345 related articles for article (PubMed ID: 33796887)
21. Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results.
Bokstein F; Blumenthal DT; Corn BW; Gez E; Matceyevsky D; Shtraus N; Ram Z; Kanner AA
J Neurooncol; 2016 Feb; 126(3):551-7. PubMed ID: 26603164
[TBL] [Abstract][Full Text] [Related]
22. Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis.
Hu YJ; Zhang LF; Ding C; Chen D; Chen J
Clin Neurol Neurosurg; 2019 Aug; 183():105401. PubMed ID: 31260910
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
Song A; Andrews DW; Werner-Wasik M; Kim L; Glass J; Bar-Ad V; Evans JJ; Farrell CJ; Judy KD; Daskalakis C; Zhan T; Shi W
Radiother Oncol; 2019 Mar; 132():135-141. PubMed ID: 30825962
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
25. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
26. Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas.
Fetcko K; Lukas RV; Watson GA; Zhang L; Dey M
Medicine (Baltimore); 2017 Oct; 96(43):e8293. PubMed ID: 29068998
[TBL] [Abstract][Full Text] [Related]
27. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis.
Hu YJ; Chen D; Zhang LF; Chen J
World Neurosurg; 2019 Jul; 127():176-185. PubMed ID: 30959254
[TBL] [Abstract][Full Text] [Related]
29. Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas.
Gregucci F; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Caliandro M; Sasso N; Bonaparte I; Fanelli V; Tortora R; Paulicelli E; Surico G; Lombardi G; Signorelli F; Fiorentino A
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013284
[TBL] [Abstract][Full Text] [Related]
30. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
Cabrera AR; Cuneo KC; Desjardins A; Sampson JH; McSherry F; Herndon JE; Peters KB; Allen K; Hoang JK; Chang Z; Craciunescu O; Vredenburgh JJ; Friedman HS; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):873-9. PubMed ID: 23725997
[TBL] [Abstract][Full Text] [Related]
31. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
[TBL] [Abstract][Full Text] [Related]
32. Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.
You WC; Lee HD; Pan HC; Chen HC
Sci Rep; 2023 Jun; 13(1):9442. PubMed ID: 37296207
[TBL] [Abstract][Full Text] [Related]
33. Target treatment with stereotactic radiation for recurrent gliomas.
Ali AS; Chen VE; Zurlo C; Taylor JM; Fernandez C; Shi W
Chin Clin Oncol; 2020 Dec; 9(6):74. PubMed ID: 32389000
[TBL] [Abstract][Full Text] [Related]
34. Initial results of a phase II trial of
Breen WG; Youland RS; Giri S; Jacobson SB; Pafundi DH; Brown PD; Hunt CH; Mahajan A; Ruff MW; Kizilbash SH; Uhm JH; Routman DM; Jones JE; Brinkmann DH; Laack NN
J Neurooncol; 2022 Jul; 158(3):323-330. PubMed ID: 35583721
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
36. Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.
Chen YL; Huang AP; Wang CC; Chen HY; Chen YF; Xiao F; Lu SL; Cheng JC; Hsu FM
J Neurooncol; 2021 Jul; 153(3):455-465. PubMed ID: 34100178
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated Radiosurgery Plus Bevacizumab for Locally Recurrent Brain Metastasis with Previously High-Dose Irradiation.
Guan Y; Wang C; Zhu H; Li J; Xu W; Sun L; Pan L; Dai J; Wang Y; Wang E; Wang X
World Neurosurg; 2020 Jan; 133():e252-e258. PubMed ID: 31505283
[TBL] [Abstract][Full Text] [Related]
38. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
39. Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists.
Furlan C; Arcangeli S; Avanzo M; Mirri MA; Munoz F; Giudici S; Perrone A; Amelio D; Tomio L; Draghini L; Deli AM; Pavanato G; Giuliano FM; Pontoriero A; Ciammella P; Navarria P; Iannalfi A; Buglione M; Guida C; Cammelli S; Iorio V; Cardinali M; Genovesi D; Barsacchi L; Balducci M; Bagnoli R; Berti F; Montesi G; Pasqualetti F; Bonome P; Santoni R; Doino D; Schirru P; Pinzi V; Borzillo V; Ferrarese F; Ferro M; Cicco L; Krengli M; Scoccianti S; Donato V
Tumori; 2018 Dec; 104(6):466-470. PubMed ID: 28315510
[TBL] [Abstract][Full Text] [Related]
40. Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.
Ene CI; Macomber MW; Barber JK; Ferreira MJ; Ellenbogen RG; Holland EC; Rockhill JK; Silbergeld DL; Halasz LM
Neurosurgery; 2019 Aug; 85(2):E322-E331. PubMed ID: 30576476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
